Robert Olstein - Olstein Capital Management 13F Activity & Position Changes (Q1 2014)

As of Mar 31, 2014, the Olstein Capital Management portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Apr 21, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q1 2014, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q1 2014
A
Agilent Technologies, Inc.
Sell - Position Exit
-85,000
Q1 2014
AAPL
Apple Inc.
Buy
+1,000
Q1 2014
ABM
ABM Industries Incorporated
Buy
+14,900
Q1 2014
ABT
Abbott Laboratories
Buy
+3,000
Q1 2014
ADI
Analog Devices, Inc.
Sell - Position Exit
-100,000
Q1 2014
ALK
Alaska Air Group, Inc.
Sell
-14,000
Q1 2014
BAX
Baxter International Inc.
Sell
-9,000
Q1 2014
BDX
Becton, Dickinson and Company
Sell
-8,000
Q1 2014
BIG
Sell
-53,000
Q1 2014
BK
The Bank of New York Mellon Cor
Buy
+108,000
Q1 2014
CECO
CECO Environmental Corp.
Buy
+47,000
Q1 2014
CMCSA
Comcast Corporation
Buy
+38,000
Q1 2014
CMI
Cummins Inc.
Sell
-9,300
Q1 2014
CRL
Charles River Laboratories Inte
Sell
-88,000
Q1 2014
CTAS
Cintas Corporation
Sell
-7,000
Q1 2014
CVS
CVS Health Corporation
Buy - Position Entry
+92,000
Q1 2014
DAL
Delta Air Lines, Inc.
Sell
-41,000
Q1 2014
DDS
Dillard's, Inc.
Buy
+36,000
Q1 2014
DE
Deere & Company
Sell
-6,000
Q1 2014
DGX
Quest Diagnostics Incorporated
Buy
+7,000
Q1 2014
DIS
Walt Disney Company (The)
Sell
-14,900
Q1 2014
DOV
Dover Corporation
Sell - Position Exit
-29,900
Q1 2014
EBAY
eBay Inc.
Sell
-31,000
Q1 2014
EFX
Equifax, Inc.
Sell
-26,000
Q1 2014
ENTG
Entegris, Inc.
Sell
-55,400
Q1 2014
ETD
Ethan Allen Interiors Inc.
Buy
+38,000
Q1 2014
FITB
Fifth Third Bancorp
Buy - Position Entry
+223,000
Q1 2014
GLW
Corning Incorporated
Buy
+5,000
Q1 2014
GM
General Motors Company
Buy
+46,000
Q1 2014
HAE
Haemonetics Corporation
Buy - Position Entry
+14,400
Page 1 of 3